TL;DR
Turn your wind-down time into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
Huberman Lab published an episode titled “Overcome Addictions & Obsessions of All Kinds,” featuring Stanford addiction specialist Dr. Anna Lembke. The discussion covers dopamine, compulsive behaviors, control and spiritual practices; the episode page says its transcript is still under human review.
Huberman Lab has published “Overcome Addictions & Obsessions of All Kinds,” an episode featuring Dr. Anna Lembke, a Stanford addiction medicine specialist, discussing dopamine and compulsive behavior. The episode addresses addiction, risk-taking, mental preoccupation and control, while the accompanying page says its transcript is still under human review.
According to the episode page, Lembke is chief of the Addiction Medicine Dual Diagnosis Clinic at Stanford. The conversation examines how dopamine dynamics in the brain may relate to risk-taking, persistent thoughts and compulsive behaviors. The supplied description outlines the topics but does not provide detailed findings, clinical recommendations or a complete account of the discussion.
The episode also takes up what its description calls a common addiction: people’s addiction to control. It discusses prayer and spiritual practices as possible ways to open new neural pathways and interrupt unhealthy patterns, including codependence. These are topics presented in the program description, not evidence in the supplied material that a particular practice works for every person or condition.
The page lists Lembke’s books “Dopamine Nation: Finding Balance in the Age of Indulgence” and “Radical Surrender: Letting Go in a World Addicted to Control.” It also points readers to support organizations including Alcoholics Anonymous, Al-Anon Family Groups and Co-Dependents Anonymous. The page does not say that the episode replaces professional care or that the listed groups suit everyone.
How the Episode Frames Compulsive Behavior
The episode brings together addiction medicine, brain processes and everyday patterns such as obsession and a desire for control. That scope may interest listeners who do not identify with substance addiction but want to understand compulsive behaviors or codependence. The discussion’s relevance lies in connecting those subjects, while the available description does not establish that they have one cause or one solution.
For readers seeking help, the distinction between a podcast discussion and individualized treatment matters. The page names peer-support resources, but provides no assessment of a listener’s circumstances, diagnosis or care needs. Its material can point people toward subjects and organizations to explore; it cannot, on its own, determine what support is appropriate.
Popular right now
KitchenAid Classic Series 4.5-Quart Tilt-Head Stand Mixer, Onyx Black
Sony WH-1000XM6 Wireless Noise-Canceling Headphones, Black
Shark HydroVac MessMaster Cordless Wet-Dry Vacuum and Mop Combo, AW261
As an affiliate, we earn on qualifying purchases.
What the Episode Page Provides
The source is a Huberman Lab episode page describing a conversation with Lembke. It includes a list of related books, research articles, other Huberman Lab episodes and people mentioned in the discussion. The article titles span topics including dopamine, stress-related drug seeking, spirituality and brain research, but the page listing alone does not establish the conclusions of those studies.
The page states that its transcript is under human review and that a fully reviewed version will be posted later. It offers access to full transcripts and additional content through Huberman Lab Premium. The supplied source does not give an episode publication date, transcript text, or a detailed account of the guest’s statements.
““We discuss dopamine dynamics in the brain and how they impact risk-taking, mental obsession, and compulsive behaviors.””
— Huberman Lab episode description
Transcript and Claims Still Pending
The supplied source does not include the episode date, full transcript or detailed discussion, so the specific arguments and examples raised by Lembke cannot be independently assessed from this material. The page itself cautions that the transcript may contain errors while review is underway.
It is also unclear from the description what evidence or qualifications the speakers give for the proposed role of spiritual practices, or how they define “addiction to control.” The page summarizes subjects rather than presenting study results or clinical guidance. No information is provided about new treatment recommendations, changes to Stanford services or a formal clinical announcement.
Reviewed Transcript and Further Resources
Huberman Lab says it will post a fully reviewed transcript when the human review is complete. Until then, readers using the transcript should account for the page’s warning that it may contain errors. The source does not give a timeline for the review or announce a date for any related follow-up episode.
The episode page also directs readers to its listed books and peer-support organizations. Anyone concerned about addiction or compulsive behavior can use those listings as starting points, while seeking guidance from a qualified health professional for decisions about personal care.
Key Questions
What is the Huberman Lab episode about?
The episode discusses dopamine, addiction, obsession and compulsive behavior, including control and codependence, with Dr. Anna Lembke.
Who is Dr. Anna Lembke?
The episode page identifies Lembke as chief of Stanford’s Addiction Medicine Dual Diagnosis Clinic and describes her as an addiction medicine expert.
Is the episode transcript final?
No. The page says the transcript is under human review and may contain errors. It says a reviewed version will be posted later, without specifying a date.
Does the episode provide treatment advice?
The supplied page describes topics and lists support resources, but does not provide a treatment plan or individualized medical advice. Personal care decisions should be discussed with a qualified health professional.
Source: hubermanlab.com
